Asymmetric Synthesis of Stegobinone
J. Am. Chem. Soc., Vol. 118, No. 19, 1996 4565
chromatography (silica, 2% ether/hexanes): 300 MHz 1H NMR (CDCl3)
δ 0.88-1.85 (m, 26), 0.89 (d, J ) 6.9 Hz, 3), 0.92 (t, J ) 7.3 Hz, 3),
0.99 (d, J ) 7.5 Hz, 3), 3.38 (dt, J ) 3.6, 6.8 Hz, 1), 3.76-3.81 (m,
2), 4.47 (AB, J ) 11.6 Hz), 4.57 (AB, J ) 11.6 Hz), 7.22-7.39 (m,
5); 75 MHz 13C NMR (CDCl3) δ 9.51, 14.02, 14.39, 18 (br), 22.23,
25.88, 25.98, 26.46, 27.67, 28.49, 38.45, 43.04, 71.36, 82.93, 83.21,
127.19, 127.69, 128.17, 139.46; HRMS calcd for C28H45O3B (M+)
440.3462, found 440.3492. Anal. Calcd for C28H45BO3: C, 76.35;
H, 10.30; B, 2.45. Found: C, 76.49; H, 10.33; B, 2.58.
evaporator gave [R-(R*,S*)]-2-(1,2-dimethyl-3-oxopentyl)-4,4,5,5-tet-
ramethyl-1,3,2-dioxaborolane (15a) as an oil: 13 g, 54 mmol [39.7%
overall yield from [4R-(4R,5â)-4,5-dicyclohexyl-2-ethyl-1,3,2-diox-
aborolane (4)]; 1H NMR (CDCl3) δ 0.90 (d, J ) 7.3, 3 Hz, 3), 1.03 (t,
J ) 7.2 Hz, 3), 1.11 (d, J ) 7.0 Hz, 3, 1.24 (s, 12), 2.3-2.5 (m, 3),
2.62 (dq, J ) 7.1, 7.2 Hz, 1); 75 MHz 13C NMR (CDCl3) δ 7.69, 13.07,
16.01, 24.64, 24.73, 34.35, 48.63, 82.97, 215.53; HRMS calcd for
C13H25BO3 (M+) 240.1897, found 240.1874. Anal. Calcd for C13H25-
BO3: C, 65.02; H 10.49 B, 4.50. Found: C, 64.83; H, 10.20, B, 4.16.
[4R-[2(1S*,2R*,3S*),4r,5â]]-4,5-Dicyclohexyl-2-(3-hydroxy-1,2-
dimethylpentyl)-1,3,2-dioxaborolane (11). A solution of crude [4R-
[2(1S*,2R*,3S*),4R,5â]]-4,5-dicyclohexyl-2-[1,2-dimethyl-3-(phenyl-
methoxy)pentyl]-1,3,2-dioxaborolane (10) (52 g) in ethyl acetate (400
mL) was stirred with palladium on charcoal catalyst (8 g, 10%) under
1 atm of hydrogen until TLC or GC analysis showed no 10 remaining.
The mixture was filtered through a pad of Celite. Concentration in a
rotary evaporator gave a mixture of impurities [4R-(4R,5â)]-4,5-
dicyclohexyl-2-(1-methylethyl)-1,3,2-dioxaborolane and [4R-(4R,5â)]-
4,5-dicyclohexyl-2-methyl-1,3,2-dioxaborolane, together with the major
product [4R-[2(1S*,2R*,3S*),4R,5â]]-4,5-dicyclohexyl-2-(3-hydroxy-
1,2-dimethylpentyl)-1,3,2-dioxaborolane (11) (39.8 g), which was used
in the next step without further purification: 300 MHz 1H NMR
(CDCl3) δ 0.85-1.81 (m, 35), 2.10-2.25 (br, 1 H), 3.29-3.36 (m, 1),
3.80-3.84 (m, 2); 75 MHz 13C NMR (CDCl3) δ 10.37, 13.12, 15.43,
25.87, 25.97, 26.43, 27.61, 27.77, 28.42, 41.63, 42.90, 76.58, 83.36;
HRMS calcd for C21H37O2B (M+ - H2O) 332.2886, found 332.2903.
O-Benzylstegobiol {[2S-[2r,3r,6(1R*,2R*)]]-2,3-Dihydro-2,3,5-
trimethyl-6-[1-methyl-2-(phenylmethoxy)butyl]-4H-pyran-4-one} (19)
via 9-Borabicyclo[3.3.1]nonane 9-Triflate and 15a. A solution of
[R-(R*,S*)]-2-(1,2-dimethyl-3-oxopentyl)-4,4,5,5-tetramethyl-1,3,2-di-
oxaborolane (15a) (4.25 g, 17.7 mmol) in dichloromethane (60 mL)
was added dropwise at -78 °C to a mixture of 9-borabicyclo[3.3.1]-
nonane-9-triflate (0.5 M, 53 mL, 26.5 mmol; 11B NMR δ 64.7 (br)
and N,N-diisopropylethylamine (5.3 mL, 30 mmol) in dichloromethane
(60 mL). The 11B NMR spectrum of the 9-borabicyclononane 9-triflate
and N,N-diisopropylethylamine mixture showed a broad peak at -0.4
ppm. The reaction mixture was stirred at -78 °C for 2 h. A sample
was withdrawn at this time, and the 11B NMR spectrum was taken at
-20 °C. There were three major peaks at δ 0.9, 33.9, and 58.7. The
peak at δ 0.9 disappeared after 4 h at 0 °C. After the initial period at
-78 °C, the reaction mixture, which presumably contained [R-(R*,S*)]-
2-[1,2-dimethyl-3-[(9-borabicyclo[3.3.1]non-9-yl)oxy]-3-pentenyl]-
4,4,5,5-tetramethyl-1,3,2-dioxaborolane (16a), was placed in an ice-
water bath for 24 h. The mixture was cooled to -78 °C, and a solution
of aldehyde 9 (3.65 g, 17.7 mmol) in 20 mL of dichloromethane was
added via syringe. The solution was allowed to warm to 0 °C and
kept for 24 h. Ether (200 mL), 2-aminoethanol (1 g), and aqueous
ammonium chloride (100 mL) were added to the mixture. The aqueous
layer was extracted with ether (3 × 100 mL). The combined organic
layer was washed with brine (100 mL) and dried over magnesium
sulfate. Concentration in a rotary evaporator yielded a product (12.64
g) containing keto boronic ester 15a, aldehyde 9, and aldol condensation
product [1S-[1R*,2S*,4(R* and/or S*),5(R* and/or S*),6S*,7R*]]-2-
[5-hydroxy-1,2,4,6-tetramethyl-3-oxo-7-(phenylmethoxy)nonyl]-4,4,5,5-
tetramethyl-1,3,2-dioxaborolane (17a). The solution of the crude
mixture in dichloromethane (120 mL) was stirred with pyridinium
dichromate (39.9 g, 106 mmol) and molecular sieves (4 Å, 16 g) at
room temperature for 12 h. Celite was added to the mixture and stirring
was continued for 30 min. The mixture was filtered through a short
pad of Florisil. The solid was washed with ethyl acetate (200 mL).
Concentration in a rotary evaporator gave a mixture of keto boronate
14, aldehyde 9, and [1S-[1R*,2S*,4(R* and/or S*),6R*,7R*]]-4,4,5,5-
tetramethyl-2-[1,2,4,6-tetramethyl-3,5-dioxo-7-(phenylmethoxy)nonyl]-
1,3,2-dioxaborolane (18a) (9.26 g). To a solution of the above mixture
in 140 mL of THF and 70 mL of phosphate buffer (pH 8) was added
hydrogen peroxide (6.8 mL, 30%) at 0 °C. After 0.5 h, the cold bath
was removed. After 3 h at room temperature, the solution was treated
with sodium iodide and sodium thiosulfate. The THF solution was
separated from the aqueous solution. The aqueous layer was extracted
with ether (2 × 200 mL). The combined organic layer was washed
with sodium thiosulfate solution (10%, 300 mL) and dried over
magnesium sulfate. Concentration in a rotary evaporator gave a mixture
of deboronated product (7 g). A solution of the above mixture in
chloroform (32 mL) was stirred with trifluoroacetic acid (10.7 mL) at
[3S-[2(3'R*,4'S*,5'R*),3r,4â,5â)]]-2,2′-Oxybis(5-ethyl-3,4-dimethyl-
1,2-oxaborolane) (13). A solution of crude [4R-[2(1S*,2R*,3S*),4R,5â]]-
4,5-dicyclohexyl-2-(3-hydroxy-1,2-dimethylpentyl)-1,3,2-dioxaboro-
lane (11) (39.8 g) in diethyl ether (400 mL) was stirred with sodium
hydroxide (1 M, 400 mL) at room temperature for 8 h. At this point
the ratio of free (R,R)-1,2-dicyclohexyl-1,2-ethanediol to unhydrolyzed
[4R-[2(1S*,2R*,3S*),4R,5â]]-4,5-dicyclohexyl-2-(3-hydroxy-1,2-dim-
ethylpentyl)-1,3,2-dioxaborolane (11) in the ether phase was 4:1 as
determined by GC and proton NMR analysis. The 1,2-dicyclohexy-
lethanediol was removed by separating the organic layer and evaporating
diethyl ether. The oily residue was redissolved in diethyl ether (300
mL) and returned to the sodium hydroxide aqueous layer for another
8 h until GC or NMR showed no 11 left. The sodium hydroxide
aqueous layer, which presumably contained sodium [3S-(3R,4R,5â)]-
2,2-dihydroxy-3,4-dimethyl-5-ethyl-1,2-oxaborolate24 (12), was acidified
with hydrochloric acid to pH ∼2-3. The solution was extracted with
ethyl acetate (2 × 400 mL) and dried over magnesium sulfate.
Concentration in a rotary evaporator gave pure [3S-[2(3'R*,4'S*,5'R*),-
(3R,4â,5â)]-2,2′-oxybis(5-ethyl-3,4-dimethyl-1,2-oxaborolane) (13): 8.5
g [47% overall yield from [4R-(4R,5â)-4,5-dicyclohexyl-2-ethyl-1,3,2-
1
dioxaborolane (4)]; H NMR (CDCl3) δ 0.91 (d, J ) 7.9 Hz, 3), 0.93
(d, J ) 7.0 Hz, 3), 0.98 (t, J ) 7.3 Hz, 3), 1.40 (m, 2), 1.61 (m, 1),
1.98 (m, 1), 3.76 (dt, J ) 4.1, 7.3 Hz, 1); 75 MHz 13C NMR (CDCl3)
δ 8.18, 10.25, 13.89, 20.55 (br), 27.88, 40.43, 86.78; HRMS calcd for
C14H28B2O3 (M+) 266.2225, found 266.2196.
[R-(R*,S*)]-2-(1,2-Dimethyl-3-oxopentyl)-4,4,5,5-tetramethyl-1,3,2-
dioxaborolane (15a). A solution of [S-(3R,4R,5â)]-2,2′-oxybis(3,4-
dimethyl-5-ethyl-1,2-oxaborolane) (13) (8.5 g, 31.9 mmol) and pinacol
(11.3 g, 95.8 mmol) in diethyl ether (150 mL) was stirred at room
temperature for 1 h. Concentration in a rotary evaporator gave a
mixture of four different compounds, presumably including [1S-
(1R*,2S*,3R*)]-2-(3-hydroxy-1,2-dimethylpentyl)-4,4,5,5-tetramethyl-
1,3,2-dioxaborolane (14). One of the constituents had the composition
(13 + pinacol - H2O) [HRMS calcd for C20H40B2O4 (M+) 366.3113,
found 366.3088]. A solution of the foregoing mixture and pyridinium
dichromate (108 g) in dichloromethane (300 mL) was stirred with
molecular sieves (40 g) at room temperature for 3 h. Celite (30 g) and
silica gel (30 g) were added to the mixture, and stirring was continued
for 30 min. The mixture was filtered though a short pad of Florisil.
The solid was washed with ethyl acetate (2 × 200 mL) and then
concentrated in a rotary evaporator and purified by redissolving in
pentane (300 mL) and washing with water (2 × 200 mL). The pentane
solution was dried over magnesium sulfate. Concentration in a rotary
1
room temperature. The reaction was complete by H NMR analysis
after 50 min. Ether (200 mL) was added to the solution. The solution
was washed with sodium bicarbonate (saturated 100 mL) and dried
over magnesium sulfate. Concentration in a rotary evaporator and
separation of product by flash column chromatography (silica, 20%
ether/hexanes) gave O-benzylstegobiol (19): 2.06 g, 6.5 mmol (36.7%
from 15a); solidifies in the freezer but melts below 20 °C; 300 MHz
1H NMR (CDCl3) δ 0.97 (t, J ) 7.4 Hz, 3), 1.01 (d, J ) 7.3 Hz, 3),
1.06 (d, J ) 7 Hz, 3), 1.25 (d, J ) 6.6 Hz, 3), 1.43-1.59 (m, 1),
1.7-1.8 (m, 1), 1.77 (s, 3), 2.25 (dq, J ) 3.4, 7.3 Hz, 1), 3.02 (dq, J
) 7, 8.8 Hz, 1), 3.56 (ddd, J ) 3.5, 6.2, 8.8 Hz, 1), 4.25 (dq, J ) 3.4,
6.6 Hz, 1), 4.41 (AB, J ) 11.5 Hz, 1), 4.52 (AB, J ) 11.5 Hz, 1),
7.25-7.38 (m, 5); 13C NMR δ 8.47, 9.11, 9.45, 13.69, 16.05, 23.31,
39.28, 43.66, 71.85, 76.03, 80.92, 108.58, 127.45, 127.50, 128.29,
(24) Chemical Abstracts name: sodium [T-4-[3S-(3R*,4S*,5R*)]]-dihy-
droxy[4-methyl-3-hexanolato(2-)-C5,O3]borate(1-).